A detailed history of Dunhill Financial, LLC transactions in Amgen Inc stock. As of the latest transaction made, Dunhill Financial, LLC holds 1,098 shares of AMGN stock, worth $289,191. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,098
Previous 1,045 5.07%
Holding current value
$289,191
Previous $326 Million 8.38%
% of portfolio
0.18%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$309.38 - $337.38 $16,397 - $17,881
53 Added 5.07%
1,098 $354 Million
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $263,275 - $319,948
1,002 Added 2330.23%
1,045 $326 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $1,882 - $2,271
7 Added 19.44%
43 $12.2 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $9,205 - $10,384
36 New
36 $10.3 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.